E-mails suggest Pfizer tried to suppress study on drug
Suits say company misled on Neurontin
By Liz Kowalczyk
Globe Staff / October 8, 2008
Top drug company marketing executives suppressed a large European study suggesting their blockbuster medication Neurontin was ineffective for chronic nerve pain, and they privately strategized about how to silence a British researcher who wanted to go public with the data, according to newly filed documents and e-mails that are part of a Boston court case.
click post title for more
Showing posts with label Neurontin. Show all posts
Showing posts with label Neurontin. Show all posts
Wednesday, October 8, 2008
Subscribe to:
Posts (Atom)